|
| Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells |
|
https://doi.org/10.18632/oncotarget.27489
Tomoya Aikawa, Noriko Togashi, Koichi Iwanaga, Hiroyuki Okada, Yumi Nishiya, Shinichi Inoue, Mark J. Levis, Takeshi Isoyama
|
| 943-955 |
|
| DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway |
|
https://doi.org/10.18632/oncotarget.27493
Caroline Dafflon, Swann Gaulis, Louise Barys, Karen Kapur, Vanessa Cornacchione, Lina Schukur, Sebastian Bergling, Elisabetta Traggiai, Selina Jansky, Leon Hellmann, Barbara Schacher Engstler, Grainne Kerr, Antoine de Weck, David A. Ruddy, Ulrike Naumann, Frédéric Stauffer, Christoph Gaul, Ying Lin, Eric Billy, Andreas Weiss, Francesco Hofmann, Moriko Ito, Ralph Tiedt
|
| 956-968 |
|
| Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss |
|
https://doi.org/10.18632/oncotarget.27503
Nicci Owusu-Brackett, Ming Zhao, Argun Akcakanat, Kurt W. Evans, Erkan Yuca, Ecaterina Ileana Dumbrava, Filip Janku, Funda Meric-Bernstam
|
| 969-981 |
|
| Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment |
|
https://doi.org/10.18632/oncotarget.27517
Fiamma Buttitta, Lara Felicioni, Alessia Di Lorito, Alessio Cortellini, Luciana Irtelli, Davide Brocco, Pietro Di Marino, Donatella Traisci, Nicola D’Ostilio, Alessandra Di Paolo, Francesco Malorgio, Pasquale Assalone, Sonia Di Felice, Francesca Fabbri, Giovanni Cianci, Michele De Tursi, Antonio Marchetti
|
| 982-991 |
|
| Acute promyelocytic leukemia (APL): a review of the literature |
|
https://doi.org/10.18632/oncotarget.27513
Joaquin J. Jimenez, Ravinder S. Chale, Andrea C. Abad, Andrew V. Schally
|
| 992-1003 |
|
| Correction: A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice |
|
https://doi.org/10.18632/oncotarget.27473
Prakash Gangadaran, Xiu Juan Li, Ho Won Lee, Ji Min Oh, Senthilkumar Kalimuthu, Ramya Lakshmi Rajendran, Seung Hyun Son, Se Hwan Baek, Thoudam Debraj Singh, Liya Zhu, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee, Byeong-Cheol Ahn
|
| 1004-1005 |
|
| Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations |
|
https://doi.org/10.18632/oncotarget.27522
Alberto Cruz-Bermúdez, Carmen G. Vallejo, Ramiro J. Vicente-Blanco, María Esther Gallardo, Miguel Ángel Fernández-Moreno, Miguel Quintanilla, Rafael Garesse
|
| 1006-1006 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
